Briefs: Concord Biotech and Shelter Pharma
News

Briefs: Concord Biotech and Shelter Pharma

Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs

  • By IPP Bureau | June 08, 2024

Concord Biotech gets EUGMP certificate for Valthera facility

The Health Product Regulatory Authority of Ireland has Issued EUGMP Certificate for our Unit II (Valthera facility) of the Company, located at 297-298/2p, Valthera, Dholka - 382225 in Ahmedabad, Gujarat.

Shelter Pharma receives order of US$ 120,000

Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs, FerroCure Capsule 30000 pcs, CoughNill 200ml x 10000 pcs, stonyl 10000 pcs, RoyalForte Capsule 10000 pcs, Total Order worth $1,20,000.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International